
Sanofi appoints external affairs VP
pharmafile | May 27, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Sanofi, suresh kumarÂ
Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice president of external affairs.
Kumar joins Sanofi from London-based consultancy firm Oliver Wyman, and in this newly-created role will be responsible for defining Sanofi’s strategy and priorities for public affairs activities.
“Suresh brings a genuinely unique profile to Sanofi that includes a diversified, international career within the healthcare industry, public sector leadership experience and an intimate understanding of NGOs,” says Olivier Brandicourt, chief executive of Sanofi.
“Suresh’s deep relationships with business and government leaders worldwide and his passion for making an impact on improving lives through healthcare will make Suresh a valuable addition to Sanofi and the executive committee.”
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






